Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1997 Mar;90(3):144–150. doi: 10.1177/014107689709000308

Rosacea: classification and treatment.

T Jansen 1, G Plewig 1
PMCID: PMC1296179  PMID: 9135612

Full text

PDF
144

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYRES S., Jr, AYRES S., 3rd Demodectic eruptions (demodicidosis) in the human. 30 years' experience with 2 commonly unrecognized entities: pityriasis folliculorum (Demodex) and acne rosacea (Demodex type). Arch Dermatol. 1961 May;83:816–827. doi: 10.1001/archderm.1961.01580110104016. [DOI] [PubMed] [Google Scholar]
  2. Aizawa H., Niimura M. Oral spironolactone therapy in male patients with rosacea. J Dermatol. 1992 May;19(5):293–297. doi: 10.1111/j.1346-8138.1992.tb03227.x. [DOI] [PubMed] [Google Scholar]
  3. Ayres S., Jr Extrafacial rosacea is rare but does exist. J Am Acad Dermatol. 1987 Feb;16(2 Pt 1):391–392. doi: 10.1016/s0190-9622(87)80138-x. [DOI] [PubMed] [Google Scholar]
  4. BORRIE P. The state of the blood vessels of the face in rosacea. I. Br J Dermatol. 1955 Jan;67(1):5–8. doi: 10.1111/j.1365-2133.1955.tb12649.x. [DOI] [PubMed] [Google Scholar]
  5. BORRIE P. The state of the blood vessels of the face in rosacea. II. Br J Dermatol. 1955 Feb;67(2):73–75. doi: 10.1111/j.1365-2133.1955.tb12690.x. [DOI] [PubMed] [Google Scholar]
  6. Berg M., Lidén S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69(5):419–423. [PubMed] [Google Scholar]
  7. Blom I., Hornmark A. M. Topical treatment with sulfur 10 per cent for rosacea. Acta Derm Venereol. 1984;64(4):358–359. [PubMed] [Google Scholar]
  8. Browning D. J., Proia A. D. Ocular rosacea. Surv Ophthalmol. 1986 Nov-Dec;31(3):145–158. doi: 10.1016/0039-6257(86)90034-2. [DOI] [PubMed] [Google Scholar]
  9. Burton J. L., Pye R. J., Meyrick G., Shuster S. The sebum excretion rate in rosacea. Br J Dermatol. 1975 May;92(5):541–543. doi: 10.1111/j.1365-2133.1975.tb03122.x. [DOI] [PubMed] [Google Scholar]
  10. Cunliffe W. J., Dodman B., Binner J. G. Clonidine and facial flushing in rosacea. Br Med J. 1977 Jan 8;1(6053):105–105. doi: 10.1136/bmj.1.6053.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Döring H. F., Ilgner M. Rosaceatherapie mit Bifonazol-Creme--praktische Erfahrungen über 2-Jahre. Z Hautkr. 1986 Apr 1;61(7):490–494. [PubMed] [Google Scholar]
  12. Esterly N. B., Furey N. L., Flanagan L. E. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol. 1978 Jan;70(1):51–55. doi: 10.1111/1523-1747.ep12543487. [DOI] [PubMed] [Google Scholar]
  13. Fry L., Swann J. C. Gastrocamera studies in rosacea. Br J Dermatol. 1968 Nov;80(11):737–739. doi: 10.1111/j.1365-2133.1968.tb11935.x. [DOI] [PubMed] [Google Scholar]
  14. Gubisch W. Das Otophym--Eine Rarität. HNO. 1983 Feb;31(2):56–58. [PubMed] [Google Scholar]
  15. Hoting E., Paul E., Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol. 1986 Dec;25(10):660–663. doi: 10.1111/j.1365-4362.1986.tb04533.x. [DOI] [PubMed] [Google Scholar]
  16. Knight A. G., Vickers C. F. A follow-up of tetracycline-treated rosacea. With special reference to rosacea keratitis. Br J Dermatol. 1975 Nov;93(5):577–580. doi: 10.1111/j.1365-2133.1975.tb02252.x. [DOI] [PubMed] [Google Scholar]
  17. Laugier P., Gilardi S. L'cedème érythémateux chronique facial supérieur (Degos). Ann Dermatol Venereol. 1981;108(6-7):507–513. [PubMed] [Google Scholar]
  18. Lloyd K. M. Surgical correction of rhinophyma. Arch Dermatol. 1990 Jun;126(6):721–723. [PubMed] [Google Scholar]
  19. Marks J., Shuster S. Small-intestinal mucosal abnormalities in various skin diseases--fact or fancy? Gut. 1970 Apr;11(4):281–291. doi: 10.1136/gut.11.4.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marks R., Dawber R. P. Skin surface biopsy: an improved technique for the examination of the horny layer. Br J Dermatol. 1971 Feb;84(2):117–123. doi: 10.1111/j.1365-2133.1971.tb06853.x. [DOI] [PubMed] [Google Scholar]
  21. Marks R., Harcourt-Webster J. N. Histopathology of rosacea. Arch Dermatol. 1969 Dec;100(6):683–691. [PubMed] [Google Scholar]
  22. Marsden J. R., Shuster S., Neugebauer M. Response of rosacea to isotretinoin. Clin Exp Dermatol. 1984 Sep;9(5):484–488. doi: 10.1111/j.1365-2230.1984.tb00842.x. [DOI] [PubMed] [Google Scholar]
  23. Mullanax M. G., Kierland R. R. Granulomatous rosacea. Arch Dermatol. 1970 Feb;101(2):206–211. [PubMed] [Google Scholar]
  24. Plewig G., Braun-Falco O., Klövekorn W., Luderschmidt C. Isotretinoin zur örtlichen Behandlung von Akne und Rosazea sowie tierexperimentelle Untersuchungen mit Isotretinoin und Arotinoid. Hautarzt. 1986 Mar;37(3):138–141. [PubMed] [Google Scholar]
  25. Plewig G., Jansen T., Kligman A. M. Pyoderma faciale. A review and report of 20 additional cases: is it rosacea? Arch Dermatol. 1992 Dec;128(12):1611–1617. doi: 10.1001/archderm.128.12.1611. [DOI] [PubMed] [Google Scholar]
  26. Plewig G., Nikolowski J., Wolff H. H. Action of isotretinoin in acne rosacea and gram-negative folliculitis. J Am Acad Dermatol. 1982 Apr;6(4 Pt 2 Suppl):766–785. doi: 10.1016/s0190-9622(82)70067-2. [DOI] [PubMed] [Google Scholar]
  27. Polla L. L., Tan O. T., Garden J. M., Parrish J. A. Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia. Dermatologica. 1987;174(1):11–17. doi: 10.1159/000248973. [DOI] [PubMed] [Google Scholar]
  28. ROWELL N. R., SUMMERSCALES J. W. Urinary excretion of 5-hydroxyindoleacetic acid in rosacea. J Invest Dermatol. 1961 Jun;36:405–406. doi: 10.1038/jid.1961.63. [DOI] [PubMed] [Google Scholar]
  29. Ramelet A. A., Perroulaz G. Rosacée: étude histopathologique de 75 cas. Ann Dermatol Venereol. 1988;115(8):801–806. [PubMed] [Google Scholar]
  30. Rebora A., Drago F., Parodi A. May Helicobacter pylori be important for dermatologists? Dermatology. 1995;191(1):6–8. doi: 10.1159/000246470. [DOI] [PubMed] [Google Scholar]
  31. Robinson T. W. Demodex folliculorum and rosacea. A clinical and histological study. Arch Dermatol. 1965 Nov;92(5):542–544. [PubMed] [Google Scholar]
  32. Rosen T., Stone M. S. Acne rosacea in blacks. J Am Acad Dermatol. 1987 Jul;17(1):70–73. doi: 10.1016/s0190-9622(87)70173-x. [DOI] [PubMed] [Google Scholar]
  33. SOBYE P. Aetiology and pathogenesis of rosacea. Acta Derm Venereol. 1950;30(2):137–158. [PubMed] [Google Scholar]
  34. Saihan E. M., Burton J. L. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol. 1980 Apr;102(4):443–445. doi: 10.1111/j.1365-2133.1980.tb06558.x. [DOI] [PubMed] [Google Scholar]
  35. Salo O. P. SLE-like deposition of immunoglobulins in the skin in rosacea. A clinical and immunofluorescent study. Ann Clin Res. 1970 Mar;2(1):28–31. [PubMed] [Google Scholar]
  36. Schmadel L. K., McEvoy G. K. Topical metronidazole: a new therapy for rosacea. Clin Pharm. 1990 Feb;9(2):94–101. [PubMed] [Google Scholar]
  37. Schmidt J. B., Gebhart W., Raff M., Spona J. 13-cis-Retinoic acid in rosacea. Clinical and laboratory findings. Acta Derm Venereol. 1984;64(1):15–21. [PubMed] [Google Scholar]
  38. Seiji M., Otaki N. Haber's syndrome. Familial rosacea-like dermatosis with keratotic plaques and pitted scars. Arch Dermatol. 1971 Apr;103(4):452–455. doi: 10.1001/archderm.103.4.452. [DOI] [PubMed] [Google Scholar]
  39. Sneddon I. B. A clinical trial of tetracycline in rosacea. Br J Dermatol. 1966 Dec;78(12):649–652. doi: 10.1111/j.1365-2133.1966.tb12168.x. [DOI] [PubMed] [Google Scholar]
  40. Starr P. A., Macdonald A. Oculocutaneous aspects of rosacea. Proc R Soc Med. 1969 Jan;62(1):9–11. [PMC free article] [PubMed] [Google Scholar]
  41. Tan S. G., Cunliffe W. J. Rosacea and migraine. Br Med J. 1976 Jan 3;1(6000):21–21. doi: 10.1136/bmj.1.6000.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tope W. D., Sangueza O. P. Rhinophyma's fibrous variant. Histopathology and immunohistochemistry. Am J Dermatopathol. 1994 Jun;16(3):307–310. [PubMed] [Google Scholar]
  43. Turjanmaa K., Reunala T. Isotretinoin treatment of rosacea. Acta Derm Venereol. 1987;67(1):89–91. [PubMed] [Google Scholar]
  44. Wilkin J. K., DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol. 1993 Jan;32(1):65–67. doi: 10.1111/j.1365-4362.1993.tb00974.x. [DOI] [PubMed] [Google Scholar]
  45. Wilkin J. K. Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol. 1983 Mar;119(3):211–214. [PubMed] [Google Scholar]
  46. Wilkin J. K. Rosacea. Pathophysiology and treatment. Arch Dermatol. 1994 Mar;130(3):359–362. doi: 10.1001/archderm.130.3.359. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES